Update on statins: 2003.
Vaughan
Carl J
CJ
Division of Cardiology, Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA.
Gotto
Antonio M
AM
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000517:prevention & control; D008078:Cholesterol, LDL / Q000097:blood; D003402:Creatine Kinase / Q000097:blood; D052283:Creatine Kinase, MM Form; D004347:Drug Interactions; D005260:Female; D006801:Humans; D006903:Hydroxymethylglutaryl CoA Reductases / Q000502:physiology; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D006937:Hypercholesterolemia / Q000188:drug therapy; D008658:Inactivation, Metabolic; D007527:Isoenzymes / Q000097:blood; D008297:Male; D008798:Mevalonic Acid / Q000494:pharmacology; D008875:Middle Aged; D008954:Models, Biological; D009135:Muscular Diseases / Q000097:blood / Q000139:chemically induced; D011446:Prospective Studies; D017368:Protein Prenylation / Q000187:drug effects; D016032:Randomized Controlled Trials as Topic; D013329:Structure-Activity Relationship
D015415:Biomarkers; D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007527:Isoenzymes; D006903:Hydroxymethylglutaryl CoA Reductases; D003402:Creatine Kinase; D052283:Creatine Kinase, MM Form; D008798:Mevalonic Acid